CHLOROTRIANISENE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Chlorotrianisene, and when can generic versions of Chlorotrianisene launch?
Chlorotrianisene is a drug marketed by Banner Pharmacaps and is included in one NDA.
The generic ingredient in CHLOROTRIANISENE is chlorotrianisene. There is one drug master file entry for this compound. Additional details are available on the chlorotrianisene profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CHLOROTRIANISENE?
- What are the global sales for CHLOROTRIANISENE?
- What is Average Wholesale Price for CHLOROTRIANISENE?
Summary for CHLOROTRIANISENE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 59 |
| Clinical Trials: | 1 |
| Patent Applications: | 2,225 |
| DailyMed Link: | CHLOROTRIANISENE at DailyMed |
Recent Clinical Trials for CHLOROTRIANISENE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Federal University of São Paulo | Phase 4 |
| Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |
Medical Subject Heading (MeSH) Categories for CHLOROTRIANISENE
Anatomical Therapeutic Chemical (ATC) Classes for CHLOROTRIANISENE
US Patents and Regulatory Information for CHLOROTRIANISENE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Banner Pharmacaps | CHLOROTRIANISENE | chlorotrianisene | CAPSULE;ORAL | 084652-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
